Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis
Authors:
- Henrik S. ThomsenHTHenrik S. Thomsen
- Monika MeuselMMMonika Meusel
- 1 July 1998
- journal article
- research article
- Published by Elsevier in Academic Radiology
- Vol. 5 (7) , 491-502
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Frequency of Acute Adverse Events to a Non-Ionic Low-Osmolar Contrast Medium: The Effect of Verbal InterviewBasic & Clinical Pharmacology & Toxicology, 1997
- Nephrotoxicity of high‐dose gadolinium compared with iodinated contrastJournal of Magnetic Resonance Imaging, 1996
- Biodistribution of Radiolabeled, Formulated Gadopentetate, Gadoteridol, Gadoterate, and Gadodiamide in Mice and RatsInvestigative Radiology, 1995
- Detection and quantitation of gadolinium chelates in human serum and urine by high-performance liquid chromatography and post-column derivatization of gadolinium with Arsenazo IIIJournal of Pharmaceutical and Biomedical Analysis, 1995
- Dialysis is not indicated immediately after administration of nonionic contrast agents in patients with end-stage renal disease treated by maintenance dialysis.American Journal of Roentgenology, 1994
- Clearance of iopamidol, a non-ionic contrast medium, by CAPD in patients with end-stage renal failureBritish Journal of Radiology, 1992
- A Phase I Clinical Trial with Gadodiamide Injection, a Nonionic Magnetic Resonance Imaging Enhancement AgentInvestigative Radiology, 1991
- Pharmacokinetics of Gd-DTPA in Patients with Chronic Renal FailureInvestigative Radiology, 1991
- Removal of Iodinated Contrast Material by Peritoneal DialysisNephron, 1974
- A Simple Method for the Determination of Glomerular Filtration RateScandinavian Journal of Clinical and Laboratory Investigation, 1972